The structural and compositional changes of glycosaminoglycans are closely associated with tissue type in human laryngeal cancer.
Hyaluronan and sulfated glycosaminoglycans, as intrinsic components of proteoglycans, are playing important roles in cancer biology. In the present study, we investigated in detail the glycosaminoglycans on both fine chemical and structural levels in laryngeal cartilaginous and non-cartilaginous tissues at different stages of laryngeal cancer. The results indicated that in cartilaginous tissues the amounts of chondroitin sulfate, keratan sulfate, dermatan sulfate and hyaluronan presented a dramatic decrease in contrast to the non-cartilaginous tissues, which showed a significant increase of these glycosaminoglycans compared to their normal counterparts. On fine chemical structure, the molar ratios of 4-sulfated to 6-sulfated and non-sulfated to sulfated disaccharides from both cartilaginous and non-cartilaginous cancerous tissues showed a significant increase. On molecular-size level, in laryngeal cancer, the chromatographic behaviour of the sulfated glycosaminoglycan chains from both tissue-types revealed their lower M(r) with a more polydisperse and heterogeneous distribution compared to the normal ones. In addition, in both tissues, a significant decrease of high molecular-size hyaluronan was observed. Of particular interest was the great increase of hyaluronan of low molecular mass in the laryngeal non-cartilaginous tissues, which ranged from 330 to 890 kDa. The kind and the extent of these alterations, which presented an intense stage-related behaviour, depended on the tissue origin and could be associated with the malignant phenotype of human laryngeal cancer.
Skandalis
Spyros S
SS
Laboratory of Biochemistry, Department of Chemistry, School of Natural Sciences, University of Patras, 265 00 Patras, Greece.
Stylianou
Marina
M
Vynios
Demitrios H
DH
Papageorgakopoulou
Nickoletta
N
Theocharis
Dimitrios A
DA
D002356:Cartilage / Q000737:chemistry; D016022:Case-Control Studies; D002809:Chondroitin Sulfates / Q000737:chemistry; D003871:Dermatan Sulfate / Q000737:chemistry; D006025:Glycosaminoglycans / Q000032:analysis / Q000737:chemistry* / Q000302:isolation & purification; D006801:Humans; D006820:Hyaluronic Acid / Q000737:chemistry; D007632:Keratan Sulfate / Q000737:chemistry; D007822:Laryngeal Neoplasms / Q000473:pathology*; D008970:Molecular Weight; D009367:Neoplasm Staging; D014018:Tissue Distribution
D006025:Glycosaminoglycans; D003871:Dermatan Sulfate; D006820:Hyaluronic Acid; D002809:Chondroitin Sulfates; D007632:Keratan Sulfate